You are here

Philips to buy cardiac devices firm Spectranetics for US$1.7b

London

ROYAL Philips NV's US$1.7 billion deal to buy Spectranetics Corp, a US maker of devices to treat cardiac disease, shows the Dutch company is moving more aggressively to bolster its growing health-care business.

Philips will offer US$38.50 a share in cash for the Colorado

sentifi.com

Market voices on:

Editor's Choice

Powered by GET.comGetCom